Related Experiment Videos
High dose versus low dose dexamethasone in experimental epidural spinal cord compression
J Y Delattre1, E Arbit, M K Rosenblum
1Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York.
Neurosurgery
|June 1, 1988
Summary
Dexamethasone treatment improved motor function in paraplegic rats caused by methylcellulose-silicone implants. Both high and low doses showed similar recovery rates, but high doses increased mortality due to infections and bleeding.
Area of Science:
- Neuroscience
- Pharmacology
- Biomaterials Science
Background:
- Methylcellulose-silicone implants can induce paraplegia in rats.
- Epidural space implantation is a model for spinal cord injury research.
Purpose of the Study:
- To evaluate the efficacy of dexamethasone in treating paraplegia induced by methylcellulose-silicone implants.
- To compare the effects of high-dose (HD) versus low-dose (LD) dexamethasone on motor recovery and survival.
Main Methods:
- A methylcellulose-silicone expanding compound was implanted in the epidural space of rats, causing paraplegia.
- Paraplegic rats were randomized into untreated control, HD dexamethasone, and LD dexamethasone groups.
- Motor strength was assessed daily by an observer blinded to treatment allocation.
Main Results:
- Dexamethasone treatment (HD or LD) accelerated motor function recovery compared to controls.
- No significant difference in recovery rate or motor improvement was observed between HD and LD dexamethasone groups.
- Mortality was higher in the HD group, primarily due to infections and gastrointestinal complications.
Conclusions:
- Dexamethasone demonstrates therapeutic potential for paraplegia induced by methylcellulose-silicone implants.
- Lower doses of dexamethasone may be preferable due to reduced mortality risk.
- Further research is needed to optimize dexamethasone dosage and administration for spinal cord injury.